Inquire About a Product| Product: | Alendronate sodium salt | ||||
|---|---|---|---|---|---|
| Catalog Number: | 5392 | ||||
| CAS Number: | 121268-17-5 | ||||
| Synonyms: | Alendronate Sodium Trihydrate; 4-amino-1-hydroxy-1-phosphonobutyl phosphoric acid, monosodium; MK-217 | ||||
| Pricing: |
|
||||
| Formula: | C4H12NaNO7P2 • 3H2O | ||||
| Chemical Purity: | >97% | ||||
| Molecular Weight: | 325.12 | ||||
| Structure: |
|
||||
| Appearance: | Solid | ||||
| Category: | Unlabeled Reference Standards | ||||
| Stability: | Stable under recommended storage conditions | ||||
| Storage: |
Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: -20°C |
||||
| Transportation: |
Non-hazardous for transport |
||||
| Literature References: |
Hussein, O., et al., Breast Cancer Cells Inhibit Spontaneous And Bisphosphonate-induced Osteoclast Apoptosis. Bone 48, 202-11, (2011); Ma, W.L., et al., New bone formation with teriparatide (human parathyroid hormone 1-34) is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats. Endocrinology 144, 2008-2015, (2003); Merck 14,229 |
||||
| MSDS: | |||||
| Description: |
Alendronate sodium trihydrate is a bone resorption inhibitor; farnesyl diphosphate synthase inhibitor (IC50 = 460 nM); CD45 protein tyrosine phosphatase inhibitor |